Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-28

Clinical Trial Update: Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 mass-balance study of radiolabeled HSK39297 in healthy Chinese adult male volunteers has been completed, with Paroxysmal nocturnal hemoglobinuria (PNH) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HSK39297

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 1 | Status: COMPLETED